======= LPAR5 ======= == Gene Information == * **Official Symbol**: LPAR5 * **Official Name**: lysophosphatidic acid receptor 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57121|57121]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H1C0|Q9H1C0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LPAR5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LPAR5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606926|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. |7tm 1| |behavioral response to pain| |positive regulation of CREB transcription factor activity| |response to pain| |multicellular organismal response to stress| |positive regulation of DNA-binding transcription factor activity| |regulation of DNA-binding transcription factor activity| |cellular component| |behavior| |G protein-coupled receptor activity| |molecular function| |G protein-coupled receptor signaling pathway| |positive regulation of molecular function| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.51| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.88| |[[:results:exp534|Trientine 500μM R08 exp534]]|-1.74| |[[:results:exp124|GSK343 3μM R03 exp124]]|1.7| |[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|1.87| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.92| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.08| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.24| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|2.31| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|2.73| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|3.25| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.93| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|4.22| ^Gene^Correlation^ |[[:human genes:p:pdcl|PDCL]]|0.47| |[[:human genes:p:ppp3r1|PPP3R1]]|0.459| |[[:human genes:g:gna15|GNA15]]|0.42| |[[:human genes:p:ppp3ca|PPP3CA]]|0.412| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18692 * **Expression level (log2 read counts)**: 5.31 {{:chemogenomics:nalm6 dist.png?nolink |}}